(TARS) Tarsus Pharmaceuticals - Performance 65.2% in 12m
Compare TARS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
50.47%
#16 in Group
Rel. Strength
92.77%
#578 in Universe
Total Return 12m
65.16%
#17 in Group
Total Return 5y
152.24%
#15 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -4.62%
16th Percentile in Group
12m Total Return: TARS (65.2%) vs XLV (1.7%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
| LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
| NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
| SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
| SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
| SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: TARS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TARS
| Total Return (including Dividends) | TARS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 1.05% | -3.79% | -0.87% |
| 3 Months | -3.44% | -3.99% | -7.58% |
| 12 Months | 65.16% | 1.72% | 11.88% |
| 5 Years | 152.24% | 55.40% | 110.33% |
| Trend Score (consistency of price movement) | TARS | XLV | S&P 500 |
| 1 Month | 54.6% | -3.2% | 23% |
| 3 Months | -18.6% | -71.4% | -88.5% |
| 12 Months | 74.4% | -17.5% | 55.1% |
| 5 Years | 22.4% | 89.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #85 | 5.04% | 1.93% |
| 3 Month | #71 | 0.57% | 4.48% |
| 12 Month | #18 | 62.4% | 47.6% |
| 5 Years | #12 | 80.6% | 48.1% |
FAQs
Does TARS Tarsus Pharmaceuticals outperforms the market?
Yes,
over the last 12 months TARS made 65.16%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months TARS made -3.44%, while XLV made -3.99%.
Over the last 3 months TARS made -3.44%, while XLV made -3.99%.
Performance Comparison TARS vs Indeces and Sectors
TARS vs. Indices TARS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.25% | 1.92% | 18.5% | 53.3% |
| US NASDAQ 100 | QQQ | -0.78% | -0.35% | 18.1% | 52.5% |
| US Dow Jones Industrial 30 | DIA | 1.19% | 4.23% | 18.6% | 56.0% |
| German DAX 40 | DAX | 1.48% | -0.27% | -0.98% | 40.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.21% | 3.87% | 21.5% | 59.2% |
| Hongkong Hang Seng | HSI | 1.24% | 0.99% | 16.6% | 51.3% |
| India NIFTY 50 | INDA | 3.09% | -3.01% | 18.3% | 62.1% |
| Brasil Bovespa | EWZ | 1.05% | -3.55% | 14.8% | 71.0% |
TARS vs. Sectors TARS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | - | 2.10% | 12.4% | 41.2% |
| Consumer Discretionary | XLY | 0.17% | 1.15% | 16.0% | 51.8% |
| Consumer Staples | XLP | 3.75% | 0.85% | 13.2% | 54.0% |
| Energy | XLE | 4.73% | 14.9% | 24.3% | 76.3% |
| Financial | XLF | 1.64% | 3.16% | 10.9% | 42.5% |
| Health Care | XLV | 0.33% | 4.84% | 20.2% | 63.4% |
| Industrial | XLI | -0.17% | 0.94% | 17.8% | 55.6% |
| Materials | XLB | 0.86% | 3.48% | 26.0% | 68.7% |
| Real Estate | XLRE | 1.77% | 2.36% | 19.4% | 47.1% |
| Technology | XLK | -2.20% | -0.64% | 21.9% | 57.4% |
| Utilities | XLU | 3.09% | 0.99% | 16.4% | 43.3% |
| Aerospace & Defense | XAR | -0.70% | -5.34% | 5.01% | 38.6% |
| Biotech | XBI | -1.05% | -1.23% | 31.2% | 67.0% |
| Homebuilder | XHB | 0.94% | 3.32% | 33.4% | 72.2% |
| Retail | XRT | 1.82% | 1.61% | 24.1% | 67.9% |